BCRX

#1599
BioCryst Pharmaceuticals, Inc. - Common Stock
8.9 1 USD
-1.87%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
8.91
8.91
Year Range
6.00
11.31
Daily Change
-1.87%
Monthly Change
-1.11%
6 month change
+25.85%
Year Change
-17.88%
Previous Close
9.0 8
Open
8.9 1
Low
8.9 1
High
8.9 1
Volume
277
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

News